DiscoverMotley Fool MoneyYou Can’t Patent LSD
You Can’t Patent LSD

You Can’t Patent LSD

Update: 2024-11-23
Share

Description

Mary Long caught up with Motley Fool Contributor Keith Speights to check in on the psychedelic industry. They discuss:  

- Advice to investors looking at a highly speculative industry.

- The cash and regulatory questions for these companies. 

- Key differences between the cannabis market and psychedelic stocks.

- The challenges of doing a double-blind test on psychedelic compounds.


Companies discussed: CMPS, CYBN, ATAI


Host: Mary Long

Guest: Keith Speights

Producer: Ricky Mulvey 

Engineers: Rick Engdahl, Desireé Jones

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

You Can’t Patent LSD

You Can’t Patent LSD

The Motley Fool